Hypertension
Hypertension(高血压)
Hypertension 相关产品(161)
- GC520483-hydroxy-4-Methoxyphenethylamine (hydrochloride)CAS: 645-33-0纯度: >98.00%
A metabolite of dopamine
- GC52281Losartan AzideCAS: 727718-93-6纯度: >95.00%
A potential impurity in commercial preparations of losartan
- GC52303Ethyl MycophenolateCAS: 32483-51-5纯度: >98.00%
A potential impurity found in commercial preparations of mycophenolate mofetil
- GC52310L-Arginine-13C6 (hydrochloride)CAS: 201740-91-2纯度: >95.00% / >98.50%
An internal standard for the quantification of L-arginine
- GC52404γ-Glu-Phe (trifluoroacetate salt)纯度: >98.00%
A dipeptide with metabolism-altering activity
- GC52415Angiotensin A (trifluoroacetate salt)纯度: >98.00%
An AT 1 and AT 2 receptor agonist and active metabolite of angiotensin II
- GC60842FinerenoneCAS: 1050477-31-0纯度: >99.50%
非奈利酮（Finerenone；BAY 94-8862）是第三代选择性、具有口服活性的、非甾体类盐皮质激素受体 （MR）拮抗剂，IC 50 为18 nM。
- GC62026Devaleryl Valsartan ImpurityCAS: 676129-92-3纯度: >99.50%
A potential impurity found in commercial preparations of valsartan
- GC92012MT-1207 (hydrochloride)纯度: >98.00%
MT-1207 (hydrochloride)是一种口服活性和选择性肾上腺素能α1和5-HT2A受体拮抗剂。MT-1207对α1A、α1B、α1D和5-HT2A的IC50分别小于0.1 nM、0.15 nM、1.40 nM和0.27 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49880 | Bradykinin (trifluoroacetate salt) | - | >95.00% | |
An endogenous vasodilator | ||||
| GC52006 | CB-096 | 108883-90-5 | >98.00% | |
An inhibitor of RAN translation | ||||
| GC52019 | Norpropranolol (hydrochloride) | 62618-09-1 | >98.00% | |
An active metabolite of propranolol | ||||
| GC52034 | Quinaprilat | 82768-85-2 | >90.00% | |
An ACE inhibitor and active metabolite of quinapril | ||||
| GC52035 | Esmolol Acid (hydrochloride) | 83356-60-9 | >98.00% | |
An active metabolite of esmolol | ||||
| GC52048 | 3-hydroxy-4-Methoxyphenethylamine (hydrochloride) | 645-33-0 | >98.00% | |
A metabolite of dopamine | ||||
| GC52281 | Losartan Azide | 727718-93-6 | >95.00% | |
A potential impurity in commercial preparations of losartan | ||||
| GC52303 | Ethyl Mycophenolate | 32483-51-5 | >98.00% | |
A potential impurity found in commercial preparations of mycophenolate mofetil | ||||
| GC52310 | L-Arginine-13C6 (hydrochloride) | 201740-91-2 | >95.00% / >98.50% | |
An internal standard for the quantification of L-arginine | ||||
| GC52404 | γ-Glu-Phe (trifluoroacetate salt) | - | >98.00% | |
A dipeptide with metabolism-altering activity | ||||
| GC52415 | Angiotensin A (trifluoroacetate salt) | - | >98.00% | |
An AT 1 and AT 2 receptor agonist and active metabolite of angiotensin II | ||||
| GC52424 | Bradykinin Fragment (1-5) (trifluoroacetate salt) | - | >98.00% | |
A metabolite of bradykinin | ||||
| GC52478 | Telmisartan Acyl-β-D-Glucuronide (hydrate) | - | >95.00% | |
A major metabolite of telmisartan | ||||
| GC60842 | Finerenone | 1050477-31-0 | >99.50% | |
非奈利酮（Finerenone；BAY 94-8862）是第三代选择性、具有口服活性的、非甾体类盐皮质激素受体 （MR）拮抗剂，IC 50 为18 nM。 | ||||
| GC62026 | Devaleryl Valsartan Impurity | 676129-92-3 | >99.50% | |
A potential impurity found in commercial preparations of valsartan | ||||
| GC63298 | Ganoderic acid N | 110241-19-5 | >98.00% | |
A triterpene with ACE inhibitory activity | ||||
| GC92012 | MT-1207 (hydrochloride) | - | >98.00% | |
MT-1207 (hydrochloride)是一种口服活性和选择性肾上腺素能α1和5-HT2A受体拮抗剂。MT-1207对α1A、α1B、α1D和5-HT2A的IC50分别小于0.1 nM、0.15 nM、1.40 nM和0.27 nM。 | ||||